ITMS 26240120031

Centre of Excellence for Glycomics

Organization: Institute of Molecular Physiology and Genetics SAS
Principal Investigator: Zdena Sulová
Duration: 2010-2014
Program: EU Structural Funds Research and Development

Coordinator: Ján Mucha (Instiute of Chemistry SAS)


  • Insitute of Chemistry SAS (principal partner)
  • Institute of Molecular Physiology and Genetics SAS
  • Institute of Experimental Pharmacology and Toxicology SAS
  • Institute for Heart research SAS
  • Institute of Molecular Biology SAS
  • Institute of Zoology SAS
  • Institute of Experimental Oncology SAS
  • Comenius University Faculty of Pharmacy


  • Imrichova D, Messingerova L, Seres M, Kavcova H, Pavlikova L, Coculova M, Breier A, Sulova Z. Selection of resistant acute myeloid leukemia SKM-1 and MOLM-13 cells by vincristine-, mitoxantrone- and lenalidomide-induced upregulation of P-glycoprotein activity and downregulation of CD33 cell surface exposure. Eur J Pharm Sci. 77 (2015) 29-39.
  • Messingerova L, Jonasova A, Barancik M, Polekova L, Seres M, Gibalova L, Breier A, Sulova Z. Lenalidomide treatment induced the normalization of marker protein levels in blood plasma of patients with 5q-myelodysplastic syndrome. Gen Physiol Biophys. 34 (2015) 399–406
  • Seres M, Pavlikova L, Sulova Z, Breier A. Lectin detection of cell surface saccharides remodeling induced by development of P-glycoprotin mediated multidrug resistance phenotype in L1210 leukemia cells. Acta Chimica Slovaca, 7 (2014) no. 1, 52-56.